These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232 [TBL] [Abstract][Full Text] [Related]
5. Uremic toxin indoxyl sulfate induces dysfunction of vascular smooth muscle cells via integrin-β1/ERK signaling pathway. Yu H; Zhou C; Hu D; Li C; Wang Q; Xue W; Peng A Clin Exp Nephrol; 2022 Jul; 26(7):640-648. PubMed ID: 35333997 [TBL] [Abstract][Full Text] [Related]
6. Uremic toxins activate CREB/ATF1 in endothelial cells related to chronic kidney disease. Stafim da Cunha R; Gregório PC; Maciel RAP; Favretto G; Franco CRC; Gonçalves JP; de Azevedo MLV; Pecoits-Filho R; Stinghen AEM Biochem Pharmacol; 2022 Apr; 198():114984. PubMed ID: 35245485 [TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514 [TBL] [Abstract][Full Text] [Related]
8. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight. Chao CT; Lin SH Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937 [TBL] [Abstract][Full Text] [Related]
9. The cardiovascular effect of the uremic solute indole-3 acetic acid. Dou L; Sallée M; Cerini C; Poitevin S; Gondouin B; Jourde-Chiche N; Fallague K; Brunet P; Calaf R; Dussol B; Mallet B; Dignat-George F; Burtey S J Am Soc Nephrol; 2015 Apr; 26(4):876-87. PubMed ID: 25145928 [TBL] [Abstract][Full Text] [Related]
10. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425 [TBL] [Abstract][Full Text] [Related]
12. The role and mechanism of RIPK1 in vascular endothelial dysfunction in chronic kidney disease. Wang C; Chen H; Su H; Sheng Q; Lang Y; Yu Q; Lv Z; Wang R FASEB J; 2024 Feb; 38(2):e23446. PubMed ID: 38275125 [TBL] [Abstract][Full Text] [Related]
13. The role of AMP-activated protein kinase α1-mediated endoplasmic reticulum stress in alleviating the toxic effect of uremic toxin indoxyl sulfate on vascular endothelial cells by Klotho. Chen C; Wu L; Xie C; Zhao X; Mao H; Xing C J Appl Toxicol; 2021 Sep; 41(9):1446-1455. PubMed ID: 33458837 [TBL] [Abstract][Full Text] [Related]
14. Uremic endothelial-derived extracellular vesicles: Mechanisms of formation and their role in cell adhesion, cell migration, inflammation, and oxidative stress. Favretto G; da Cunha RS; Flores Santos A; Leitolis A; Schiefer EM; Gregório PC; Franco CRC; Massy Z; Dalboni MA; Stinghen AEM Toxicol Lett; 2021 Sep; 347():12-22. PubMed ID: 33945863 [TBL] [Abstract][Full Text] [Related]
15. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632 [TBL] [Abstract][Full Text] [Related]